RealClearHealth February 29, 2016 Archives

RealClearHealth AM Update

Top PhRMA Lobbyist Threads a Thicket of Outrage

Robert Pear NYT

Aetna CEO Vows Support for Exchanges Amid Losses

C. Terhune KHN

Health Quality An Issue For Poor, Poll Finds

Joe Neel NPR

Doctors Promoting Treatments on Social Media

Sheila Kaplan Stat

Dr. Phil Is Not an M.D., But Is Paid Drug Spokesman

Julia Belluz Vox

Senate Readies for Battle over Opioid Abuse

Jordain Carney The Hill

New Twist in Addiction Crisis: Deadly Impostors

Welsh-Huggins AP

OB-GYNs Navigate Catholic Hospitals' Ethics Rules

Rebecca Plevin KPCC

Controversial Home Visits Duck Medicare's Radar

Bob Herman ModHC

Poll: Many Parents Downplay Value of Flu Shot

Robert Preidt HealthDay

13 Smart Ways to Cut High Drug Costs

Kara Brandeisky Time

Pros & Cons of Selling Insurance Across State Lines

Joseph R. Antos AEI

Rubio's Responsible Rebuttal to Trumpcare

Ramesh Ponnuru Bloomberg

Readmissions, Observation, and Improving Care

Ashish Jha THCB

HIV's Toll on Black and Latino Men

New York Times

RealClearHealth PM Update

AARP: Drug Prices Greatly Outpaced Inflation

Ed Silverman Pharmalot

Selling a $1,000 Pill for $10 Without Losing Money

Caroline Chen B'berg

Affordability Is the Most Urgent Health Reform Issue

Timothy Jost HA

Candidates' Varying Explanations for Health Costs

Peter Ubel Forbes

Why Republicans Can't Embrace Obamacare

Stein & Cherkis Huff. Post

New Kind of Worker May Keep Patients Healthier

Stacey Burling PI

'Female Libido' Pill May Not Be Worth It

Dennis Thompson HealthDay

Reject the Pseudoscience of Homeopathy

Edzard Ernst Stat